Dyskinesia - Pipeline Review, H1 2018
SKU ID :GMD-11171648 | Published Date: 13-Mar-2018 | No. of pages: 160Description
TOC
Table of Contents
Table of Contents 2
Introduction 5
Dyskinesia - Overview 6
Dyskinesia - Therapeutics Development 7
Dyskinesia - Therapeutics Assessment 16
Dyskinesia - Companies Involved in Therapeutics Development 25
Dyskinesia - Drug Profiles 35
Dyskinesia - Dormant Projects 141
Dyskinesia - Discontinued Products 143
Dyskinesia - Product Development Milestones 144
Appendix 154
Tables & Figures
List of Tables
Number of Products under Development for Dyskinesia, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Dyskinesia - Pipeline by Adamas Pharmaceuticals Inc, H1 2018
Dyskinesia - Pipeline by Addex Therapeutics Ltd, H1 2018
Dyskinesia - Pipeline by Advicenne SA, H1 2018
Dyskinesia - Pipeline by Amarantus Bioscience Holdings Inc, H1 2018
Dyskinesia - Pipeline by Avanir Pharmaceuticals Inc, H1 2018
Dyskinesia - Pipeline by Bionomics Ltd, H1 2018
Dyskinesia - Pipeline by Cadent Therapeutics, H1 2018
Dyskinesia - Pipeline by Cavion LLC, H1 2018
Dyskinesia - Pipeline by Clevexel Pharma SAS, H1 2018
Dyskinesia - Pipeline by EpiVax Inc, H1 2018
Dyskinesia - Pipeline by Heptares Therapeutics Ltd, H1 2018
Dyskinesia - Pipeline by Ipsen SA, H1 2018
Dyskinesia - Pipeline by IRLAB Therapeutics AB, H1 2018
Dyskinesia - Pipeline by Medy-Tox Inc, H1 2018
Dyskinesia - Pipeline by Merz Pharma GmbH & Co KgaA, H1 2018
Dyskinesia - Pipeline by Neurim Pharmaceuticals Ltd, H1 2018
Dyskinesia - Pipeline by Neurocrine Biosciences Inc, H1 2018
Dyskinesia - Pipeline by Neurolixis Inc, H1 2018
Dyskinesia - Pipeline by Phenomenome Discoveries Inc, H1 2018
Dyskinesia - Pipeline by Sage Therapeutics Inc, H1 2018
Dyskinesia - Pipeline by SciFluor Life Sciences LLC, H1 2018
Dyskinesia - Pipeline by SOM Biotech SL, H1 2018
Dyskinesia - Pipeline by Synchroneuron Inc, H1 2018
Dyskinesia - Dormant Projects, H1 2018
Dyskinesia - Dormant Projects, H1 2018 (Contd..1), H1 2018
Dyskinesia - Discontinued Products, H1 2018List of Figures
Number of Products under Development for Dyskinesia, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
Companies
- PRICE
-
$2000$6000